Company Filing History:
1 out of 91 
1 out of 1 
1 out of 5 Years Active: 2017
Title: Christine Meisinger: Innovator in Diabetes Research
Introduction
Christine Meisinger is a notable inventor based in Aichach, Germany. She has made significant contributions to the field of diabetes research, particularly in identifying biomarkers for type 2 diabetes. Her innovative work has the potential to impact the way diabetes is diagnosed and treated.
Latest Patents
Christine Meisinger holds a patent for a method of identifying a predisposition for developing type 2 diabetes mellitus. This method involves assessing specific metabolites in a sample obtained from a subject. The invention highlights the importance of certain metabolites, such as glycine and acetylcarnitine C2, in predicting the risk of developing type 2 diabetes. Additionally, her patent includes methods for identifying compounds that can prevent diabetes and related diseases, as well as a kit for these assessments.
Career Highlights
Throughout her career, Christine has worked with prestigious organizations, including Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt and Deutsche Diabetes-Forschungsgesellschaft e.V. - Träger des Deutschen Diabetes-Zentrums Düsseldorf. Her work in these institutions has furthered the understanding of diabetes and its prevention.
Collaborations
Christine has collaborated with esteemed colleagues, including Wolfgang Rathmann and Christian Herder. These partnerships have enriched her research and contributed to advancements in diabetes studies.
Conclusion
Christine Meisinger is a pioneering inventor whose work in diabetes research is paving the way for innovative diagnostic and therapeutic approaches. Her contributions are vital in the ongoing battle against type 2 diabetes.